Mitophagy in cisplatin-induced kidney injury: regulatory mechanisms and therapeutic targets
Background Cisplatin is a first-line chemotherapeutic agent widely used in clinical oncology, but its clinical utility is severely limited by cisplatin-induced acute kidney injury (Cis-AKI). Renal tubular epithelial cells (RTECs) are the main target of cisplatin-induced damage, and the pathogenesis...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2026-12-01
|
| Reeks: | Annals of Medicine |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/07853890.2026.2672141 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|